Background: Familial Mediterranean fever (FMF) is an IL-1b-dependent autoinflammatory disease caused by mutations of Mediterranean fever (MEFV) encoding pyrin and characterized by inflammatory attacks induced by physical or psychological stress. Objective: We investigated the underlying mechanism that links stress-induced inflammatory attacks with neutrophil activation and release of IL-1b-bearing neutrophil extracellular traps (NETs) in patients with FMF.
Results: The stress-related protein regulated in development and DNA damage responses 1 (REDD1) is significantly overexpressed during FMF attacks. Neutrophils from patients with FMF during remission are resistant to autophagy-mediated NET release, which can be overcome through REDD1 induction. Stress-related mediators (eg, epinephrine) decrease this threshold, leading to autophagy-driven NET release, whereas the synchronous inflammatory environment of FMF attack leads to intracellular production of IL-1b and its release through NETs. REDD1 in autolysosomes colocalizes with pyrin and nucleotide-binding domain, leucine-rich repeat/pyrin domain-containing 3. Mutated pyrin prohibits this colocalization, leading to higher IL-1b levels on NETs. Conclusions: This study provides a link between stress and initiation of inflammatory attacks in patients with FMF. REDD1 emerges as a regulator of neutrophil function upstream to pyrin, is involved in NET release and regulation of IL-1b, and might constitute an important piece in the IL-1b-mediated inflammation puzzle. (J Allergy Clin Immunol 2017;140:1378-87.)
Key words: Regulated in development and DNA damage responses 1, familiar Mediterranean fever, autophagy, neutrophil extracellular traps, IL-1b, stress, inflammation Familial Mediterranean fever (FMF) is a prototype inherited autoinflammatory disorder associated with mutations in the Mediterranean fever (MEFV) gene (gene ID: 4210) encoding the protein pyrin (tripartite motif 20) . FMF is characterized by unpredictable, recurrent, and self-limited inflammatory attacks of fever and serositis. Several factors associated with emotional and physical stress are proposed to trigger FMF attacks. 1, 2 FMF is a member of the IL-1b-dependent family of autoinflammatory disorders characterized by their clinical response to IL-1b blockade. [3] [4] [5] The first well-defined, IL-1b-mediated inflammatory phenotype has been described in patients with cryopyrin-associated periodic syndrome, which is caused by aberrant activation of NACHT, LRR, and PYD domain-containing protein 3 (NLRP3) inflammasome. 6 Since then, in patients with various disorders, genetic or not, the role of the NLRP3 inflammasome has been suggested. [3] [4] [5] Neutrophils comprise the main effector cell population during acute inflammation in patients with FMF. 7, 8 Pyrin is highly expressed in neutrophils and associated with increased IL-1b bioactivity. [9] [10] [11] [12] [13] During FMF attacks, neutrophils release chromatin filaments, known as neutrophil extracellular traps (NETs), bearing bioactive IL-1b. 14 Recent experimental evidence suggests a significant role of autophagy in patients with FMF because neutrophils from patients with FMF are characterized by low basal autophagic levels, whereas autophagy is necessary for NET formation during disease attacks. 14, 15 Additionally, pyrin acts as a receptor for the selective autophagic degradation of inflammasome components, a function that is significantly impaired in mutated protein. 16 However, how the autophagy/NET/IL-1b axis is activated and regulated, leading to inflammatory flares of FMF, is not yet clear.
Here we identified DNA damage-inducible transcript 4 (DDIT4)/regulated in development and DNA damage responses 1 (REDD1) protein as a critical mediator of stress-induced neutrophil activation and NET release in patients with FMF and investigated its role in the regulation of NET-associated IL-1b.
METHODS Patients
Neutrophils and sera were isolated from 6 patients with FMF during disease attack and remission and from another 5 patients with FMF in remission (mean age, 32.7 6 8.8 years; see Table E1 in this article's Online Repository at www.jacionline.org). Neutrophils, PBMCs, and sera were also isolated from 25 sex-and age-matched healthy subjects, who served as control subjects (12 male and 13 female subjects; mean age, 32.4 6 9.9 years). Additionally, neutrophils and sera from 5 patients with active systemic adult-onset Still's disease (AOSD; 2 male and 3 female patients; mean age, 29.0 6 17.8 years) and 15 patients with acute bacterial infections (mean age, 67.0 6 18.1 years; see Table E2 in this article's Online Repository at www.jacionline.org) were collected. Patients with AOSD and infections were used as disease control groups of sterile and nonsterile inflammation, respectively. Informed consent was obtained from each patient and control subject.
Diagnosis of FMF was made according to the Tel-Hashomer criteria, 17 and genetic confirmation was carried out, as previously described. 18 Patients at disease attack experienced a typical clinical picture (abdominal pain and/or arthritis and fever >388C), neutrophilia, and increased C-reactive protein values. Patients during remission were asymptomatic and had normal laboratory values at least 4 weeks after and/or 1 week before attack. Diagnosis of AOSD was based on criteria from Yamaguchi et al. 19 During sampling, all patients were febrile (>388C) and presented with arthralgia/arthritis (n 5 5), sore throat/pharyngitis (n 5 5), rash (n 5 3), lymphadenopathy (n 5 3), splenomegaly (n 5 2), pleuritis (n 5 1), neutrophilia, increased C-reactive protein values, and high serum ferritin levels (>500 mg/L). Patients with infections were recruited according to the following criteria: (1) fever of 38.58C or greater and (2) proved bacterial infection (clinical and/or microbial isolation, see Table E2 ). Furthermore, none of the patients with FMF and AOSD experienced other acute or chronic disease during the study.
The study protocol was in accordance with the Helsinki Declaration, and all procedures were approved by the local ethics committee (Scientific Committee of the University Hospital of Alexandroupolis, Greece).
Detailed information for all methods can be found in the in the Methods section in this article's Online Repository at www.jacionline.org.
RESULTS

DDIT4/REDD1 is upregulated in neutrophils during FMF attacks
Genome-wide RNA sequencing was performed for the analysis of gene expression in neutrophils from patients with FMF during remission and inflammatory attacks and control subjects (control neutrophils). Paired analysis in 3 patients with FMF who were sampled during attack and remission indicated that 12 genes were differentially expressed (Fig 1, A and B , and see Table E3 in this article's Online Repository at www.jacionline.org). In addition, unpaired analysis of differential expression showed that 6 genes had a significant differential expression between patients with FMF in remission (n 5 8) and control subjects (n 5 8; see Fig E1 and Table E4 in this article's Online Repository at www.jacionline.org).
Because DDIT4/REDD1 (hereafter referred as REDD1, gene ID: 54541) was the most significantly upregulated target encoding a protein induced by stress, [20] [21] [22] [23] [24] [25] we further validated its expression levels. Neutrophils from patients undergoing FMF attack demonstrated significantly higher REDD1 mRNA expression, as shown by using quantitative PCR (Fig 1, C) , and protein levels, as shown by using immunoblotting (Fig 1, D) , compared with neutrophils from patients with FMF remission and control subjects. REDD1 overexpression was associated with increased autophagic levels, as shown by consumption of p62/sequestosome 1 (SQSTM1) in immunoblotting (Fig 1, D) . These findings suggest that overexpression of REDD1 is associated with autophagy induction during FMF attacks, suggesting a possible link between them.
REDD1 induction activates NET release in neutrophils from patients with FMF by reducing the threshold of autophagy activation Based on the low basal autophagy levels and the resistance of neutrophils from patients under remission to form NETs, 14, 15 we investigated whether REDD1 is involved in this process.
Using a REDD1 chemical inducer, 26 we initially observed that induction of REDD1 transcription was impaired in neutrophils from patients in FMF remission because significantly higher concentrations (>70 mmol/L) were required for the increase of REDD1 mRNA levels in neutrophils from patients in FMF remission compared with those from control subjects (> _10 mmol/L; Fig 2, A) . We demonstrated further that REDD1 induction promotes autophagy, as studied based on LC3B immunofluorescence (Fig 2, B) and p62/SQSTM1 immunoblotting (Fig 2, C) and NET release in control neutrophils (Fig 2, D-F, arrows) , whereas neutrophils from patients in FMF remission required significantly higher concentrations of REDD1 inducer similar to those required for the induction of REDD1 transcription (Fig 2, F , and see Fig E2 in this article's Online Repository at www.jacionline.org). Pretreatment with the autophagy inhibitor wortmannin abolished both autophagy induction (Fig 2, B and C) and the subsequent REDD1-mediated NET release, as assessed by means of immunofluorescence (Fig 2,  D) and myeloperoxidase (MPO)/DNA complex ELISA (Fig 2, E) . These findings demonstrate that upregulation of REDD1 induces NET generation in an autophagy-dependent manner, whereas the resistance of neutrophils from patients in FMF remission to REDD1 induction is further reflected by a resistance in NET release. (Fig 1, A) and heat map (Fig 1, B ; false discovery rate < 0.05) analysis between neutrophils from patients with FMF attacks and neutrophils from patients in remission (n 5 3). In Fig 1, A, b-tubulin (TUBB) is displayed as a negative control. C and D, REDD1 mRNA levels (Fig 1, C ; n 5 6) and REDD1 or p62/SQSTM1 immunoblotting (Fig 1, D; n 5 4) in neutrophils from patients with FMF attacks in comparison with neutrophils from patients in FMF remission and those from control subjects. In Fig 1, A and C, data are presented as means 6 SDs. *P < .05.
Neutrophils from control subjects and patients in FMF remission were incubated with serum isolated during FMF attacks to further link REDD1 expression in neutrophils with the inflammatory milieu during FMF attacks. This resulted in a significant upregulation of REDD1 gene expression only in neutrophils from control subjects (Fig 2, G) . Of interest, on synchronous stimulation with low doses of REDD1 chemical inducer (10-30 mmol/L) and sera from patients with FMF attacks, REDD1 mRNA levels in neutrophils from patients in FMF remission reached levels observed in control cells (Fig 2, A) , enabling NET formation (Fig 2, F and H, arrow). These findings suggest that neutrophils of patients with FMF become prone to REDD1 induction if both sera from patients with FMF attacks and additional low doses of REDD1 inducers are present.
Both REDD1-driven NET formation and IL-1b-expressing neutrophils are required for inflammatory attack
We have previously demonstrated that FMF attack is characterized in vivo by NETs loaded with active IL-1b. 14 The in vitro treatment of neutrophils from patients in FMF remission with sera from patients with FMF attacks alone resulted in IL-1b expression without induction of NET formation.
14 Because
REDD1 induction results in NET release (Fig 2, F and H), we further investigated whether REDD1-induced NETs expressed IL-1b. We detected no IL-1b expression in NETs released by neutrophils from patients in FMF remission in response to REDD1 inducer (Fig 3, arrows) . However, incubation of neutrophils with a combination of REDD1 inducer and sera from patients with FMF attacks resulted in release of intracellular IL-1b through NETs, such as in the setting attacks (Fig 3, double arrow ).
REDD1-induced autophagy regulates the bioactivity of IL-1b by interfering with the NLRP3 inflammasome
Because it has been previously shown that pyrin drives inflammasome components for degradation into autophagosomes, 16 we further studied whether REDD1 induction and subsequent activation of autophagy is involved in IL-1b processing and release by neutrophils. Given that neutrophils from patients in FMF remission are resistant to REDD1 induction in terms of autophagy induction, both cells from patients in FMF remission and control subjects were incubated with sera from patients with FMF attacks in the presence of REDD1 inducer. Treatment of neutrophils from control subjects resulted in the assembly of pyrin and REDD1 in intracellular structures in (Fig 2, C) . D and E, REDD1-induced NET release is autophagy mediated. F, Induction of NET release in neutrophils from patients in FMF remission compared with those from control subjects. G, REDD1 expression in neutrophils from control subjects compared with those from patients in FMF remission treated with sera from patients with FMF attacks. H, Induction of NET release in neutrophils from patients in FMF remission. Fig 2, D and H, Green, neutrophil elastase (NE); red, CitH3. In Fig 2, A-H, n 5 6. Bars show means 6 SDs. *P < .05.
cytoplasm (Fig 4,
A, arrowhead) positive for the lysosomal dye LysoTracker, corresponding to autolysosomes (REDD1 autolysosomes). Additionally, nucleotide-binding domain, leucine-rich repeat/pyrin domain-containing 3 (NALP3) was localized in these structures (Fig 4, A, dotted arrow) . In contrast, in neutrophils from patients in FMF remission, we observed the formation of pyrin (Fig 4, B , arrow) and NALP3 (Fig 4, B , double-dotted arrow) aggregates, suggesting NLRP3 inflammasome activation, which did not localize with REDD1 or LysoTracker (Fig 4, B , double arrow). These findings were further strengthened by observing a similar localization pattern in ex vivo staining experiments during FMF attacks (Fig 4, C) , suggesting that REDD1 activation drives pyrin and NALP3 into autolysosomes, whereas mutations on exon 10 of pyrin impair this process.
We further evaluated whether the above-described localization differences of pyrin and NLRP3 affect IL-1b production and release through NETs. Indeed, the amount of IL-1b on NETs from stimulated neutrophils from patients in FMF remission (pyrin and NLRP3 are not colocalized with REDD1 in autolysosomes) was significantly higher compared with that in neutrophils from control subjects, as shown by using immunoblotting (Fig 4, D) and NET ELISA (Fig 4, E) . Because, use of a standard ELISA for the detection of IL-1b both in serum and cell-cultures supernatants is not reliable, 4,14 the performed NET ELISA showed a certain pattern of IL-1b measurements, verifying NETs as the main locus of its expression. To further confirm that IL-1b on NETs is bioactive, we treated control PBMCs with them, as previously described.
14 As was expected, higher production of pro-IL-1b in PBMCs was observed when NETs generated by stimulated neutrophils from patients in FMF remission were used (Fig 4, F, Based on all previous experiments, it is suggested that the autolysosomes induced by REDD1 activation contain pyrin and NLRP3 inflammasome structures. In the case of mutated pyrin, this assembly into autolysosomes is prohibited, resulting in enhanced inflammasome-driven generation of mature IL-1b on NETs.
Epinephrine is an inducer of REDD1 expression in neutrophils
Because stress has been linked to FMF flares 2, 17, 27 and REDD1 is a stress-induced mediator, [20] [21] [22] [23] [24] [25] we next tried to decode whether stress mediators are involved in REDD1 upregulation during an FMF attack. Thus we selected representative stress and inflammation-related agents as stimuli, such as epinephrine, endothelin-1, thrombin, and IL-1b, and examined their effects on REDD1 expression on both neutrophils from control subjects and those from patients in FMF remission. Among these agents, epinephrine induced significant REDD1 overexpression in neutrophils from patients in FMF remission (Fig 5, A) and control subjects (data not shown) and promoted NET release. NETs generated by using epinephrine did not express IL-1b (Fig 5, B,  arrow) . The additional use of sera from patients with FMF attacks resulted in IL-1b expression on NETs (Fig 5, B , double arrow), whereas pretreatment with the b-adrenergic receptor antagonist propranolol abolished REDD1 upregulation (Fig 5, A) and NET release (Fig 5, B) .
The REDD1/IL-1b-bearing NET axis is linked to autoinflammation
Furthermore, we investigated whether overexpression of REDD1 is a common finding in patients with inflammatory disorders. REDD1 overexpression was observed ex vivo in neutrophils from patients with FMF attacks and active systemic AOSD (Fig 6,  A) compared with remission stages (Fig 6, C , and see Table E5 in this article's Online Repository at www.jacionline.org), as well as after in vitro stimulations of neutrophils from control subjects with corresponding serum (Fig 6, B and C) . However, no overexpression was observed in patients with bacterial infections (Fig 6, A-C , and see Table E5 ). Furthermore, IL-1b-bearing NETs were observed in neutrophils from patients with active AOSD in contrast to those with infections (see Fig E4 in this article's Online Repository at www.jacionline.org).
Because the above findings reveal a group of diseases with IL-1b-bearing NETs as a common characteristic, we further developed a flow cytometry-based assay on isolated neutrophils to differentiate inflammatory diseases according to IL-1b as a NET component. We observed that during acute episodes, FMF and AOSD were characterized by an increased percentage of citrullinated-histone H3 (CitH3)/CD66b double-positive cells that represent NET-forming neutrophils (Fig 7, A, B , and D) 28 and a high frequency of neutrophils staining positively for IL-1b (Fig 7, A, C , and D) compared with those in healthy control subjects or patients with infections, who demonstrated only high CitH3 counts. In addition, we found similar results after in vitro (Fig 4, A) or neutrophils from patients in FMF remission (Fig 4, B) treated with sera from patients with FMF attacks in the presence of REDD1 inducer (10 mmol/L) and ex vivo isolated neutrophils from patients with FMF attacks (Fig 4, C; magenta, REDD1; green, pyrin or NALP3; red, LysoTracker). D and E, IL-1b expression in purified NET proteins (Fig 4, D) or on isolated NET structures from neutrophils from control subjects or neutrophils from patients in FMF remission on treatment with sera from patients with FMF attacks in the presence of REDD1 inducer (10 mmol/L; Fig 4, E) . F, IL-1b protein expression in PBMCs from control subjects treated with NET structures generated by double-stimulated neutrophils from patients in FMF remission or control subjects. Fig 4, A-F (Fig 6, A) and in neutrophils from control subjects treated with corresponding serum (Fig 6, B) . Data are presented as means 6 SDs. n.s., Not significant. *P < .05. C, Heat map analysis of REDD1 expression between neutrophils from selected similarly aged patients (FMF, AOSD, infections) with attack and those from the same patients in remission and after in vitro stimulation of neutrophils from control subjects with corresponding serum. stimulation of neutrophils from control subjects with sera obtained from patients with FMF attacks or septic patients (see Fig E5 in this article' s Online Repository at www.jacionline. org). These results demonstrate the potential diagnostic value of the REDD1/NET protein pathway.
DISCUSSION
In this study we describe a novel link between stress-associated stimuli and an FMF attack phenotype through REDD1 induction. The REDD1-mediated autophagy leads to autolysosomes containing pyrin and NALP3 regulating the maturation of IL-1b. MEFV mutations prohibit localization of pyrin and NALP3 in autolysosomes, enhancing IL-1b maturation and release through NETs.
Whole-transcriptome analysis in neutrophils of patients with FMF revealed REDD1 as the most significantly upregulated gene during disease-induced inflammatory attacks. This finding was supported by previous reports demonstrating that REDD1 is able to promote stress-induced autophagy through mechanistic target of rapamycin in primary animal cells and cell lines. [29] [30] [31] [32] To date, the inflammatory effects of REDD1 induction in human neutrophils remained unknown. Here we demonstrate that REDD1 upregulation during autoinflammatory attacks promotes autophagy and NET release in neutrophils, 2 tightly linked processes. 14, [33] [34] [35] For the first time, we describe that REDD1 induction is efficient to promote robust NET release in an In Fig 7, B and C, data are presented as means 6 SDs. n.s., Not significant. *P < .05.
autophagy-dependent manner, as indicated by ex vivo findings and in vitro inhibition studies. Thus the decoding of REDD1 inducers in real life and how they are linked with the FMF phenotype was the next challenge.
A plethora of clinical data suggests that a period of physical or psychological stress often precedes and triggers FMF attacks. 2, 27 Hence an increase in colchicine dose is advised in patients with FMF during stressful periods. 17 However, little is known about the mechanisms translating stressful life events into neutrophilmediated inflammation. 36, 37 Trying to decode inflammatory stress in the FMF attack model, we found that stimulation of neutrophils with the prototype stress hormone epinephrine 38 significantly induced REDD1 expression in neutrophils, leading to autophagy upregulation and subsequent NET release. Interestingly, increased urinary excretion of epinephrine has been described during FMF attacks, 2 whereas the sympathomimetic agent metaraminol has been used in previous decades as a diagnostic test to provoke an FMF attack. 39 Although mediators of inflammatory stress, such as the vasoconstrictive peptide endothelin-1, 40 the thromboinflammatory protease thrombin, 41 and IL-1b, 42 did not upregulate REDD1, further studies are needed to identify additional stress-related agents involved in this pathway.
The observed resistance of REDD1 induction in neutrophils from patients with FMF is consistent with previous findings describing autophagic resistance in these cells, possibly as a homeostatic adaptation to prevent frequent attacks.
14 Because NET-associated protein load largely corresponds to the disease microenvironment, 14, [43] [44] [45] we demonstrated that the inflammatory milieu of sera from patients with FMF attacks is required for the generation of NETs expressing mature IL-1b. In periods of stress (see the graphical abstract, proposed mechanism), REDD1-inducing stimuli, such as epinephrine, could function as a second hit in neutrophils that overcomes the intrinsic cell resistance to autophagy and NET release. However, the question of which inflammatory cytokines/mediators of sera from patients with FMF could participate during various stages of disease, regulating autophagy and/or IL-1b maturation of neutrophils from patients with FMF, remains to be studied in the future.
Furthermore, we show that REDD1 induction serves as a natural homeostatic response of neutrophils under inflammation to restrict IL-1b load and inflammation by driving pyrin and NALP3 into autolysosomes, which probably undergo the expected degradation in this environment. When pyrin is mutated, it no longer localizes in REDD1-positive autolysosomes, whereas it inhibits the REDD1-induced aggregation of NALP3 into these autolysosomes, resulting in higher amounts of mature IL-1b, possibly because of impaired autolysosomic inflammasome degradation. Our data are complementary to those of previous studies that demonstrated the key role of autophagy in deactivation of the inflammasome by means of degradation 46, 47 and that pyrin functions as a selective autophagy transporter of inflammasome components. 16 However, we were not able to observe any direct interaction between REDD1 and pyrin (data not shown).
Considering the above findings, it would be of interest to clarify whether the proposed mechanism is involved in further autoinflammatory and infectious disorders. For the first time, we describe that NETs expressing IL-1b are also detected in patients with AOSD, a genetically undefined IL-1b-mediated autoinflammatory syndrome. 4 Thus we developed an assay trying to distinguish autoinflammatory diseases from other febrile/ inflammatory conditions. Our first results were promising because both IL-1b and CitH3 were expressed only in ex vivo neutrophils from patients with autoinflammatory disorders, such as FMF and AOSD. In neutrophils from patients with bacterial infections, we did not observe high expression of REDD1 independently of disease severity. Additional studies are needed to establish the diagnostic value of assessing IL-1b expression in neutrophils in patients with autoinflammatory disorders.
In conclusion, in the present study we describe a pathway that links stress with the IL-1b inflammatory response in patients with FMF. REDD1 emerges as a mediator upstream to pyrin that regulates the pyrin-dependent selective trafficking of NALP3 into autolysosomes. This homeostatic function of REDD1 is severely impaired by disease-associated mutations, providing evidence for the missing link between environmental stress and IL-1b-mediated inflammation in patients with FMF.
METHODS
Library preparation and sequencing by means of synthesis
The cDNA library was prepared with the TruSeq RNA Sample Prep Kit v2 (Illumina, San Diego, Calif). Briefly, mRNA were extracted from total RNA with poly-T containing magnetic beads and transformed into single-stranded cDNA by means of reverse transcription. The second strand was synthesized before fragmentation into 260-bp cDNA fragments, and a 39-adenylation was performed to enable the ligation of index. Finally, P5 and P7 primers were incorporated by using PCR. The final cDNA concentration was determined by using quantitative PCR, and the fragmentation quality was assessed with the DNA ScreenTape assay (Agilent Technologies, Santa Clara, Calif). Two samples were sequenced on each lane with the MiSeq desktop sequencer (Illumina) to obtain 75-nt reads in the .fastq format.
Differential expression analysis
The pipeline was adapted from previous work by Anders et al. E1 Quality control of raw reads was performed with the ShortRead R package. E2 Between 19 and 38 million reads were obtained from all samples with a high quality score (>35). No significant difference was observed in the number of reads in the disease attack, remission, and control groups. Reads were aligned to the human reference genome (hg19) with TopHat2 E3 and the Burrows-Wheeler Aligner E4 with standard parameters. Resulting alignment files in the SAM format were converted and sorted with SamTools. E5 HTSeqcount E6 was used to count aligned reads corresponding to each gene of the reference genome. Considering gene expression criteria as an RPKM (reads per kilobase per million mapped reads) of greater than 1 in all replicates, 14,421 genes were expressed in control subjects, 13,492 in patients in FMF remission, and 15,549 in patients with FMF during disease attacks. Statistical analyses were performed with free open-source R language and Bioconductor software with the edgeR package. E7 Paired analysis was performed to compare FMF samples in disease attack and remission, whereas unpaired analysis was performed to compare FMF remission samples with control samples. Genes with a false discovery rate of less than 0.05 were considered significantly differentially expressed (Tables E3 and E4) .
Stimulation and inhibition studies
Neutrophils from control subjects or patients with FMF isolated either during remission or disease attack were cultured in RPMI medium (Gibco, Carlsbad, Calif) supplemented with 2% healthy subject serum at 5% CO 2 and 378C.
Neutrophils from control subjects or patients in FMF remission were treated with REDD1 chemical inducer (naphthalimide compound) at concentrations ranging from 1 to 300 mmol/L (Sigma-Aldrich, St Louis, Mo) to evaluate the implication of REDD1 in FMF pathophysiology. Moreover, stimulations were also performed with sera from patients with FMF attacks, AOSD, or bacterial infections or sera from healthy subjects (control serum) in a final concentration of 5%. Neutrophils from control subjects were pretreated with wortmannin (100 nmol/L, Sigma-Aldrich) for 30 minutes to inhibit autophagy. Neutrophils from control subjects or patients in FMF remission were incubated with epinephrine (1 nmol/L; DEMO, Athens, Greece), thrombin (0.5 U/mL; Calbiochem, San Diego, Calif), endothelin-1 peptide (100 pg/mL, Sigma-Aldrich), or recombinant human IL-1b (100 ng/mL, Sigma-Aldrich) to study the implication of mediators of stress in REDD1 induction. Neutrophils were preincubated with propranolol (1 mg/mL; Institute of Pharmaceutical Research and Technology, Athens, Greece) for 30 minutes to inhibit the effects of epinephrine. An IL-1 receptor antagonist (anakinra, 100 ng/mL) was used to inhibit IL-1b signaling.
Control PBMCs were cultured in RPMI supplemented with 2% healthy subject serum in 5% CO 2 at 378C. Cells were stimulated with NET structures derived from neutrophils from control subjects or patients in FMF remission in a 10% final concentration for 120 minutes. As control NETs, NET structures from untreated neutrophils that undergo spontaneous NET generation were used as controls. PBMCs treated with LPS (50 ng/mL, Sigma-Aldrich) were used as a positive control.
A different duration of stimulation was used depending on the assay: 45 minutes for REDD1 mRNA analysis and autophagy induction and 90 minutes for REDD1/pyrin or REDD1/NALP3 localization experiments and p62/SQSTM1 determination. The above concentrations and time points were optimal for neutrophil stimulation, according to optimizing experiments. All the substances used in this study were endotoxin free, as determined by using a Limulus amebocyte assay (Sigma-Aldrich).
RNA isolation, cDNA synthesis, and quantitative real-time PCR RNA isolation and cDNA synthesis were conducted in neutrophils, as previously described. E8 Real-time quantitative RT-PCR for DDIT4/REDD1 was performed, as described in Table E6 .
Immunofluorescence
Sample preparation and NET visualization by means of immunofluorescence confocal microscopy were performed, as previously described. E9 Samples were stained with a rabbit anti-neutrophil elastase mAb ( 
NET structure generation and isolation
In brief, 1.5 3 10 6 in vitro-stimulated neutrophils were seeded in 6-well culture plates (Corning, Corning, NY) in RPMI medium for 4 hours at 378C. NET structures were collected on supernatant medium after vigorous agitation and sequential centrifugation, as previously described. E8 
NET protein isolation
In vitro-stimulated neutrophils (1.5 3 10 6 ) were seeded in 6-well culture plates (Corning) in RPMI medium. Cells were incubated for 3 hours at 378C in a 5% CO 2 atmosphere. NET proteins were purified by using DNase I treatment and precipitated, as previously described. E8 MPO/DNA complex ELISA To quantify NET release, MPO/DNA complex was measured in NET structures isolated from 1.5 3 10 6 neutrophils, as previously described. E8 NET release was depicted as a percentage increase compared with control values.
NET ELISA
IL-1b levels were measured in NET structures isolated from 1.5 3 10 6 neutrophils (as described above) by using an IL-1b ELISA kit (R&D Systems), according to the manufacturer's instructions.
Western blot analysis
Immunoblotting was performed, as previously described. E8 An anti-REDD1 polyclonal antibody (Proteintech) was used to study REDD1 production. An mAb against IL-1b (1:400, R&D Systems) was used to detect IL-1b. Furthermore, a mouse anti-human p62/SQSTM1 polyclonal antibody (1:400 dilution, Santa Cruz Biotechnology) was used as an autophagy marker. Membranes were reprobed for glyceraldehyde-3-phosphate dehydrogenase (1:1000 dilution, Santa Cruz Biotechnology) to verify equal loading in cell lysates.
Flow cytometric analysis
After isolation of ex vivo-or in vitro-stimulated neutrophils, NET determination was performed, as previously described with minor modifications. E10 More specifically, neutrophils were permeabilized according to the manufacturer's instructions (Invitrogen FIX&PERM) and stained for intracellular citrullinated H3 (Abcam). Goat anti-rabbit IgG/IgM fluorescein isothiocyanate was used as a secondary antibody (BD Biosciences, San Jose, Calif). Additionally, each sample was stained separately for intracellular IL-1b with an IL-1b-fluorescein isothiocyanate antibody (BioLegend, San Diego, Calif). AntiCD66b-peridinin-chlorophyll-protein complex antibody (BD Biosciences) was used as a neutrophil-specific marker. Neutrophils were identified as CD66b 1 events. Analyses were performed on 10 4 gated CD66b 1 events in Cell Quest (BD Biosciences).
Statistical analysis
Statistical analyses were performed with 1-way ANOVA (Scheffe test in uniform n and least significant difference test in nonuniform n for post hoc comparisons). All statistical analyses were performed with OriginPro 8 (OriginLab). P values of less than .05 were considered significant. 
FIG E5.
IL-1b/CitH3 expression in neutrophils from control subjects stimulated in vitro with sera from patients with FMF attacks or sepsis or healthy control sera. Representative scatter plots (A) and data from flow cytometry of CitH3-or IL-1b-positive neutrophils (B and C) are shown. In Fig E5, B and C, data are presented as means 6 SDs. Fig E5, B and C, n 5 5. *P < .05. 
